Hydrolytic pathway of glufosfamide, a new phosphorylated anticancer agent

Phosphorus, Sulfur and Silicon and Related Elements

Volumn 177, Issue 6-7, 2002, Pages 1735-1738

  De Rouvèze, Marie Caroline Aoust ^a   Gilard, Veronique ^a   Martino, Robert ^a   Malet Martino, Myriam ^a   Niemeyer, Ulf ^b  

^a Université Paul Sabatier   (France)

^b ASTA MEDICA AG   (Germany)

Author keywords

31P NMR; Glufosfamide; Hydrolysis; Isophosphoramide mustard

Indexed keywords

ANTINEOPLASTIC AGENT; BUFFER; DIHYDROXYISOPHOSPHORAMIDE MUSTARD; GLUFOSFAMIDE; ISOPHOSPHORAMIDE MUSTARD; PHOSPHATE; PHOSPHOETHANOLAMINE; PHOSPHORAMIDIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG HALF LIFE; DRUG HYDROLYSIS; PH; PHOSPHORYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE;

EID: 0036406555     PISSN: 10426507     EISSN: None     Source Type: Journal    
DOI: 10.1080/10426500212229     Document Type: Conference Paper

References (3)

1. H. Seker, B. Bertram, A. Burkle, B. Kaina, J. Pohl, H. Koepsell, and M. Wiebler, Br. J. Cancer, 82, 629 (2000).
2. H. A. A. M. Dirven, L. Megens, M. J. Houdshoorn, M. A. Digemanse, B. van Ommen, and P. J. van Bladeren, Chem. Res. Toxicol., 8, 979 (1995).
3. J. H. Boal, M. Williamson, V. L. Boyd, S. M. Ludeman, and W. Egan, J. Med. Chem., 32, 1768 (1989).